Rihab Khlifi Selected Research

kaempferol-3-O-glucoside

12/2020

Erica multiflora extract rich in quercetin-3-O-glucoside and kaempferol-3-O-glucoside alleviates high fat and fructose diet-induced fatty liver disease by modulating metabolic and inflammatory pathways in Wistar rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rihab Khlifi Research Topics

Disease

2	Neoplasms (Cancer) 05/2021 - 04/2020
1	Sarcoma (Soft Tissue Sarcoma) 05/2021
1	Obesity 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Fatty Liver 12/2020
1	Inflammation (Inflammations) 12/2020
1	Insulin Resistance 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Body Weight (Weight, Body) 10/2019

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 12/2020 - 10/2019
2	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 04/2020 - 01/2020
1	Volatile Oils (Essential Oils)IBA 05/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2021
1	Adenosine Triphosphatases (ATPase)IBA 05/2021
1	isoquercitrinIBA 12/2020
1	kaempferol-3-O-glucosideIBA 12/2020
1	Methanol (Carbinol)IBA 12/2020
1	EnzymesIBA 12/2020
1	FructoseIBA 12/2020
1	Fenofibrate (CiL)FDA LinkGeneric 10/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2021
1	Oral Administration 12/2020
1	Intraperitoneal Injections 01/2020